Prospective cohort study of the risk of prostate cancer among rotating-shift workers: Findings from the Japan Collaborative Cohort Study

American Journal of Epidemiology

Volumn 164, Issue 6, 2006, Pages 549-555

  Kubo, Tatsuhiko ^a   Ozasa, Kotaro ^b   Mikami, Kazuya ^b   Wakai, Kenji ^c   Fujino, Yoshihisa ^d   Watanabe, Yoshiyuki ^b   Miki, Tsuneharu ^b   Nakao, Masahiro ^e   Hayashi, Kyohei ^b   Suzuki, Koji ^f   Mori, Mitsuru ^g   Washio, Masakazu ^g   Sakauchi, Fumio ^g   Ito, Yoshinori ^h   Yoshimura, Takesumi ⁱ   Tamakoshi, Akiko ^h  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d Fukuoka Institute of Occupational Health   (Japan)

^e MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^f FUJITA HEALTH UNIVERSITY   (Japan)

^g SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

Circadian rhythm; Cohort studies; Japan; Occupational exposure; Prostatic neoplasms; Work schedule tolerance

Indexed keywords

AGE CLASS; BASELINE SURVEY; CANCER; COHORT ANALYSIS; COMPARATIVE STUDY; HEALTH RISK; WORKING CONDITIONS;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; EDUCATION; HIGH RISK POPULATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROSTATE CANCER; SHIFT WORKER; SMOKING; STATISTICAL MODEL; STRESS; WORKPLACE;

ADULT; AGED; CIRCADIAN RHYTHM; COHORT STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; WORK SCHEDULE TOLERANCE;

ASIA; EURASIA; FAR EAST; JAPAN;

EID: 33748767394     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj232     Document Type: Article

References (35)

1. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-61.
2. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001;93:1563-8.
3. Hormonal resynchronisation-an occupational hazard. Lancet Oncol 2002;3:323.
4. Motohashi Y, Higuchi S. Shift work and health. Occup Health Rev 1999;12:125-44.
5. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
6. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7.
7. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996;7:197-204.
8. Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005;41:2023-32.
9. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95.
10. Kiss A, Meryn S. Effect of sex and gender on psychosocial aspects of prostate and breast cancer. BMJ 2001;323:1055-8.
11. Bland KI, Copeland EM III. The breast: comprehensive management of benign and malignant disorders. Philadelphia, PA: W B Saunders, 2003.
12. Walsh PC, Retik AB, Vaughan ED, et al. Campbell's urology. Philadelphia, PA: W B Saunders, 2002.
13. Tamarkin L, Danforth D, Lichter A, et al. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 1982;216:1003-5.
14. Bartsch C, Bartsch H, Schmidt A, et al. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 1992;209:153-67.
15. Hill S, Blask D. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988;48:6121-6.
16. Siu SW, Lau KW, Tam PC, et al. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002;52:106-22.
17. Ohno Y, Tamakoshi A. Japan Collaborative Cohort Study for Evaluation of Cancer Risk sponsored by Monbusho (JACC study). J Epidemiol 2001;11:144-50.
18. Tamakoshi A, Yoshimura T, Ito Y, et al. Profile of the JACC Study. J Epidemiol 2005;15:S4-S8.
19. World Health Organization. International statistical classification of diseases and related health problems. Tenth Revision. Geneva, Switzerland: World Health Organization, 1993.
20. Watanabe Y, Ozasa K, Nagura J, et al. Mortality in the JACC study till 1999. J Epidemiol 2005;15(suppl 1):S74-9.
21. Cox DR, Oakes D. Analysis of survival data. New York, NY: Chapman and Hall, 1984.
22. Schernhammer ES, Rosner B,Willett WC, et al. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004;13:936-43.
23. Goh VH, Tong TY, Lim CL, et al. Onboard a naval ship. Mil Med 2000;165:101-5.
24. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer 2004;90:941-3.
25. Moretti RM, Marelli MM, Maggi R, et al. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 2000;7:347-51.
26. Luboshitzky R, Lavi S, Thuma I, et al. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. J Clin Endocrinol Metab 1996;81:770-4.
27. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861-9.
28. Bodiwala D, Luscombe CJ, Liu S, et al. Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. Cancer Lett 2003;192:145-9.
29. Stewart LV, Weigel NL. Vitamin D and prostate cancer. Exp Biol Med 2004;229:277-84.
30. Chen TC, Holick MF. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 2003;14:423-30.
31. Wedderburn AA. How fast should the night shift rotate? A rejoinder. Ergonomics 1992;35:1447-51.
32. Touitou Y, Haus E, eds. Biologic rhythms in clinical and laboratory medicine. Berlin, Germany: Springer-Verlag, 1992.
33. Nakamura K, Yasunaga Y, Ko D, et al. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol 2002;20:543-7.
34. Nakata S, Sato J, Imai K, et al. Epidemiological characteristics of prostate cancer in Gunma Prefecture, Japan. Gunma University Urological Oncology Study Group. Int J Urol 1995;2:191-7.
35. Nomura AM. Body size and prostate cancer. Epidemiol Rev 2001;23:126-31.